Advanced search
Publication Cover
Current Medical Research and Opinion Volume 36, 2020 - Issue 5
Submit an article Journal homepage
8,882
Views
29
CrossRef citations to date
0
Altmetric
Addiction Medicine

Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations

Serena TonstadDepartment of Preventive Cardiology, Oslo University Hospital, Aker, Oslo, Norway; Correspondence[email protected]
,
Cynthia AronsPfizer Inc, New York, NY, USA;
,
Hans RollemaRollema Biomedical Consulting, Mystic, CT, USA;
,
Ivan BerlinDepartment of Pharmacology, Hôpital Pitié-Salpêtrière, Paris, France; ;Centre Universitaire de Médecine Générale et Santé Publique, Lausanne, Switzerland;
,
Peter HajekWolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK;
,
Karl FagerströmFagerström Consulting, Vaxholm, Sweden;
,
Charl ElsDepartment of Psychiatry, University of Alberta, Edmonton, AB, Canada
,
Thomas McRaePfizer Inc, New York, NY, USA;
&
Cristina RussPfizer Inc, New York, NY, USA;
show all
Pages 713-730 | Received 31 Jul 2019, Accepted 11 Feb 2020, Published online: 14 Mar 2020

Related Research Data

Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations
Source: Figshare

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.